Eptinezumab
Eptinezumab is a pharmaceutical drug with 23 clinical trials. Currently 5 active trials ongoing. Historical success rate of 92.9%.
Success Metrics
Based on 13 completed trials
Phase Distribution
Phase Distribution
3
Early Stage
1
Mid Stage
15
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
86.7%
13 of 15 finished
13.3%
2 ended early
5
trials recruiting
23
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
A Study With Eptinezumab in Children and Adolescents (6 to 17 Years) With Chronic or Episodic Migraine
Facilitators and Barriers to Eptinezumab Administration in Thailand
A Study With Eptinezumab in Adolescents (12-17 Years) With Chronic Migraine
A Study of Eptinezumab in Pediatric Participants With Episodic Migraine
A Trial of Eptinezumab in Participants With Migraine and Insufficient Response to Anti-CGRP Medications
Clinical Trials (23)
A Study With Eptinezumab in Children and Adolescents (6 to 17 Years) With Chronic or Episodic Migraine
Facilitators and Barriers to Eptinezumab Administration in Thailand
A Study With Eptinezumab in Adolescents (12-17 Years) With Chronic Migraine
A Study of Eptinezumab in Pediatric Participants With Episodic Migraine
A Trial of Eptinezumab in Participants With Migraine and Insufficient Response to Anti-CGRP Medications
A Study of Eptinezumab in Participants With Migraine and Medication Overuse Headache
China HeadAche DIsorders RegiStry
Eptinezumab as Preventive Treatment of Migraine in Adults With Migraine
Long-Term Extension Study With Eptinezumab as Preventive Treatment in Participants With Migraine in Japan
Eary Infusion of Eptinezumab for TreatmEnt of ACute Post-Traumatic Headaches (ELITE-ACT)
Migraine Medication Effects on Urinary Symptoms
A Study of CGRP Monoclonal Antibody to Treat Diabetic Neuropathy
Eptinezumab in Participants With Episodic Cluster Headache
A 1-year Trial to Inform About Long-term Exposure to Eptinezumab in Participants With Chronic Cluster Headache (cCH)
Real World Effectiveness of Eptinezumab in Participants With Migraine
Eptinezumab as an Adjunct to Standard of Care for Migraine in an Acute Emergency Context
Migraine Induction Properties of PACAP-38 After Eptinezumab in Migraine Without Aura Patients.
A Study in Children and Young People With Migraine to Learn What the Body Does to Eptinezumab
A Study to Evaluate the Efficacy and Safety of Eptinezumab for the Prevention of Migraine in Participants That Are Not Helped by Previous Preventive Treatments
Eptinezumab in Adults With Migraine and Medication Overuse Headache
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 23